...
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens
【24h】

Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens

机译:树突状细胞的预激活损害了疫苗和内源性病毒抗原的MHC II类提呈

获取原文
获取原文并翻译 | 示例
           

摘要

When dendritic cells (DCs) encounter signals associated with infection or inflammation, they become activated and undergo maturation. Mature DCs are very efficient at presenting antigens captured in association with their activating signal but fail to present subsequently encountered antigens, at least in vitro. Such impairment of MHC class II (MHC II) antigen presentation has generally been thought to be a consequence of down-regulation of endocytosis, so it might be expected that antigens synthesized by the DCs themselves (for instance, viral antigens) would still be presented by mature DCs. Here, we show that DCs matured in vivo could still capture and process soluble antigens, but were unable to present peptides derived from these antigens. Furthermore, presentation of viral antigens synthesized by the DCs themselves was also severely impaired. Indeed, i.v. injection of pathogen mimics, which caused systemic DC activation in vivo, impaired the induction of CD4 T cell responses against subsequently encountered protein antigens. This immunosuppressed state could be reversed by adoptive transfer of DCs loaded exogenously with antigens, demonstrating that impairment of CD4 T cell responses was due to lack of antigen presentation rather than to overt suppression of T cell activation. The biochemical mechanism underlying this phenomenon was the down-regulation of MHC II-peptide complex formation that accompanied DC maturation. These observations have important implications for the design of prophylactic and therapeutic DC vaccines and contribute to the understanding of the mechanisms causing immunosuppression during systemic blood infections.
机译:当树突状细胞(DC)遇到与感染或炎症相关的信号时,它们会被激活并成熟。成熟的DCs非常有效地呈递与其激活信号相关的捕获抗原,但至少在体外无法呈递随后遇到的抗原。通常认为这种MHC II类(MHC II)抗原呈递受损是内吞作用下调的结果,因此可以预期DC自身合成的抗原(例如病毒抗原)仍会呈递由成熟的区议会负责。在这里,我们表明体内成熟的DC仍然可以捕获和处理可溶性抗原,但无法呈现衍生自这些抗原的肽。此外,DC本身合成的病毒抗原的呈递也受到严重损害。的确,i.v。病原体模拟物的注射导致体内系统性DC活化,削弱了针对随后遇到的蛋白质抗原的CD4 T细胞反应的诱导。可以通过外源性加载抗原的DC的过继转移来逆转这种免疫抑制状态,这表明CD4 T细胞反应的损伤是由于缺乏抗原呈递而不是由于T细胞活化的明显抑制。造成这种现象的生化机制是伴随DC成熟的MHC II-肽复合物形成的下调。这些发现对预防性和治疗性DC疫苗的设计具有重要意义,并有助于理解全身性血液感染期间引起免疫抑制的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号